4.5 Article

Knockout of Na+-glucose cotransporter SGLT1 mitigates diabetes-induced upregulation of nitric oxide synthase NOS1 in the macula densa and glomerular hyperfiltration

期刊

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
卷 317, 期 1, 页码 F207-F217

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajprenal.00120.2019

关键词

diabetes mellitus; glomerular hyperfiltration; hypertension; neuronal nitric oxide synthase; Na+ -glucose cotransporter 2

资金

  1. National Institutes of Health (NIH) [R01-DK-112042]
  2. University of Alabama at Birmingham/University of California-San Diego O'Brien Center of Acute Kidney Injury NIH Grants [P30-DK-079337, R01-DK-106102, R01-HL-142814, DK-099276, HL-142814, HL-137987]
  3. National Natural Science Foundation of China [81800649]
  4. Natural Science Foundation of Hunan Province [2018JJ3727]
  5. Astra-Zeneca
  6. Department of Veterans Affairs

向作者/读者索取更多资源

Na+-glucose cotransporter (SGLT)1 mediates glucose reabsorption in late proximal tubules. SGLT1 also mediates macula densa (MD) sensing of an increase in luminal glucose, which increases nitric oxide (NO) synthase 1 (MD-NOS1)-mediated NO formation and potentially glomerular filtratrion rate (GFR). Here, the contribution of SGLT1 was tested by gene knockout (-/-) in type 1 diabetic Akita mice. A low-glucose diet was used to prevent intestinal malabsorption in Sglt1(-/-) mice and minimize the contribution of intestinal SGLT1. Hyperglycemia was modestly reduced in Sglt1(-/-) versus littermate wild-type Akita mice (480 vs. 550 rag/d1), associated with reduced diabetes-induced increases in GFR, kidney weight, glomerular size, and albuminuria. Blunted hyperfiltration was con- firmed in streptozotocin-induced diabetic Sglt1(-/-) mice, associated with similar hyperglycemia versus wild-type mice (350 vs. 385 mg/dl). Absence of SGLT1 attenuated upregulation of MD-NOS1 protein expression in diabetic Akita mice and in response to SGLT2 inhibition in nondiabetic mice. During SGLT2 inhibition in Akita mice, Sglt1(-/-) mice had likewise reduced blood glucose (200 vs. 300 mg/dl), associated with lesser MD-NOS1 expression, GFR, kidney weight. glomerular size, and albuminuria. Absence of Sglt1 in Akita mice increased systolic blood pressure, associated with suppressed renal renin mRNA expression. This may reflect fluid retention due to blunted hyperfiltration. SGLT2 inhibition prevented the blood pressure increase in Sglt1(-/-) Akita mice, possibly due to additive glucosuric/diuretic effects. The data indicate that SGI.T1 contributes to diabetic hyperfiltration and limits diabetic hypertension. Potential mechanisms include its role in glucose-driven upregulation of MD-NOS1 expression. This pathway may increase GFR to maintain volume balance when enhanced MD glucose delivery indicates upstream saturation of SGLTs and thus hyperreabsorption.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据